TauroPharm GmbH (8033217) - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

taurolock hep 500 - non-antibiotic-based antimicrobial catheter lock solution

tauropharm australia pty ltd - 57875 - non-antibiotic-based antimicrobial catheter lock solution - the device contains anticoagulants and antimicrobial substances. it is to be used with a port or a catheter-based vascular access device. it is to be instilled in the device lumens between treatments in order to make the internal flow passages resistant to clot formation and hostile to bacterial and fungal growth. the solution must be withdrawn prior to initiating the next treatment. taurolock-hep500 is indicated for those patients who use a port or a silicone or polyurethane catheter-based device as vascular access and is intended to be used as a catheter lock solution. it is to be instilled into the device at the termination of a treatment and withdrawn prior to initiating subsequent treatments.

Australia - English - Department of Health (Therapeutic Goods Administration)

non-antibiotic-based antimicrobial catheter lock solution

tauropharm australia pty ltd - 57875 - non-antibiotic-based antimicrobial catheter lock solution - to be instilled into the lumens of a port or catheter-based vascular access device between patient treatments in order to inhibit blood clot formation and pathogenic microbial (bacterial/fungal) growth and maintain the patency of the vascular access device. the solution is intended to be instilled at the termination of a treatment and withdrawn prior to subsequent treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

taurolock hep 100 - non-antibiotic-based antimicrobial catheter lock solution

tauropharm australia pty ltd - 57875 - non-antibiotic-based antimicrobial catheter lock solution - the device contains anticoagulants and antimicrobial substances. it is to be used with a port or a catheter-based vascular access device. it is to be instilled in the device lumens between treatments in order to make the internal flow passages resistant to clot formation and hostile to bacterial and fungal growth. the solution must be withdrawn prior to initiating the next treatment. taurolock-hep100 is indicated for those patients who use a port or a silicone or polyurethane catheter-based device as vascular access and is intended to be used as a catheter lock solution. it is to be instilled into the device at the termination of a treatment and withdrawn prior to initiating subsequent treatments.